Australia Peripheral Vascular Stents Market Size & Outlook
Australia peripheral vascular stents market, 2018-2030 (US$M)
Related Markets
Australia peripheral vascular stents market highlights
- The Australia peripheral vascular stents market generated a revenue of USD 46.8 million in 2023 and is expected to reach USD 78.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, drug eluting stents (des) was the largest revenue generating type in 2023.
- Bioabsorbable Stents is the most lucrative type segment registering the fastest growth during the forecast period.
Peripheral vascular stents market data book summary
| Market revenue in 2023 | USD 46.8 million |
| Market revenue in 2030 | USD 78.5 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Drug eluting stents (des) |
| Fastest growing segment | Bioabsorbable Stents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents |
| Key market players worldwide | MicroPort Scientific Corp, Medtronic PLC, Terumo Corp, Abbott Laboratories, BIOTRONIK, LifeTech Scientific Corp, iVascular, Stryker Corp, Cook Medical, Boston Scientific Corp, Cardinal Health Inc, Stentys |
Other key industry trends
- In terms of revenue, Australia accounted for 2.6% of the global peripheral vascular stents market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China peripheral vascular stents market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 161.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peripheral Vascular Stents Market Scope
Peripheral Vascular Stents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia peripheral vascular stents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular stents market will help companies and investors design strategic landscapes.
Drug eluting stents (des) was the largest segment with a revenue share of 61.11% in 2023. Horizon Databook has segmented the Australia peripheral vascular stents market based on drug eluting stents (des), bare metal stents (bms), bioabsorbable stents covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia peripheral vascular stents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia peripheral vascular stents market databook
-
Our clientele includes a mix of peripheral vascular stents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia peripheral vascular stents market , including forecasts for subscribers. This country databook contains high-level insights into Australia peripheral vascular stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia peripheral vascular stents market size, by type, 2018-2030 (US$M)
Australia Peripheral Vascular Stents Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
